Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Carl-Johan Dalsgaard
Vicore Pharma AB
Kronhusgatan 11
Gothenburg, SE-411 05
Sweden
Contact
Vicore Pharma AB
Email
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
71
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Seven Days Treatment With the Angiotensin II Type 2 Receptor Agonist C21 in Hospitalized COVID-19 Patients: A Placebo-Controlled Randomized Phase 2 Trial
Number of pages: 30
Posted: 23 Jul 2021
Göran Tornling
,
Rohit Batta
,
Joanna C. Porter
,
Bryan Williams
,
Thomas Bengtsson
,
Kartikeya Parmar
,
Reema Kashiva
,
Anders Hallberg
,
Anne Katrine Cohrt
,
Kate Westergaard
, Carl-Johan Dalsgaard and
Johan Raud
Karolinska Institutet, Vicore Pharma AB, University College London - Centre for inflammation and Tissue Repair, University College London, StatMind, B.J. Medical College, Asarwa, Noble Hospitals Pvt. Ltd, Hadapsar - Department of Medicine, Uppsala University, Vicore Pharma AB, Vicore Pharma AB, Vicore Pharma AB and Karolinska Institutet
Downloads
71
(875,328)
View PDF
Download
Abstract:
Feedback
